AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. EBITDA margin (%)

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥963.5B
P/E ratio
10.5x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA margin (%) YoY (%)
Mar 31, 202513.6-113.52%
Mar 31, 2024-100.8+1467.99%
Mar 31, 2023-6.4-136.52%
Mar 31, 202217.6-3.27%
Mar 31, 202118.2-12.68%
Mar 31, 202020.8+33.19%
Mar 31, 201915.6-14.49%
Mar 31, 201818.3+14.44%
Mar 31, 201716+25.88%
Mar 31, 201612.7+27.30%
Mar 31, 201510

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)